Targeting the Prion‐Like Domain of EBNA1 Inhibits Protein Aggregate Formation, Promotes SRRM1 Alternative Splicing and Inhibits Nasopharyngeal Carcinoma Progression. This evidence concerns the gene SRRM1 and nasopharyngeal carcinoma.